세계의 실데나필(Sildenafil) 의약품 시장 : 약물 유형별, 적응증별, 유통 채널별, 제형별, 지역별
Sildenafil Drug Market, By Drug Type, By Indication, By Distribution Channel, By Dosage Form, By Geography
상품코드:1741491
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
실데나필 의약품 시장은 2025년에 33억 달러, 2032년에는 52억 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 6.7%를 나타낼 전망입니다.
보고서 범위
보고서 상세
기준 연도
2024
2025년 시장 규모
33억 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측 기간(2025-2032년) CAGR
6.70%
2032년 가치 예측
52억 달러
일반적으로 작은 파란색 알약으로 알려진 실데나필은 주로 발기부전(ED) 치료에 널리 사용되는 의약품입니다. 포스포디에스터라아제 5형(PDE5) 억제제라는 약효 분류에 속하며 비아그라라는 브랜드로 판매되고 있습니다. 실데나필은 음경 혈관의 평활근을 이완시켜 혈류를 증가시켜 궁극적으로 발기를 촉진합니다.
1990년대 후반에 도입된 이후, 실데나필은 발기부전 치료 분야에 혁명을 일으켜 전 세계 수백만 명의 남성에게 도움을 주었습니다. 실데나필은 발기력 유지에 어려움을 겪는 남성들이 의지할 수 있는 약물이 되었으며, 많은 사람들의 삶을 변화시키는 효과적인 해결책을 제공합니다.
시장 역학:
실데나필 의약품 시장은 예측 기간 동안 큰 성장을 이룰 것으로 예측됩니다. 이러한 성장을 가속하는 주요 요인으로는 전 세계 발기부전 유병률 증가, 고령화 인구 증가, 성 건강에 대한 인식 증가 등을 들 수 있습니다.
하지만, 시장에는 과제도 있습니다. 심각한 억제요인은 소비자에게 심각한 건강 위험을 초래할 수 있는 실데나필 제품의 위조품이 시장에 존재한다는 것입니다. 규제 기관과 제약회사는 위조 의약품을 단속하는 데 주력하고 있습니다.
이러한 어려움에도 불구하고, 실데나필 시장에는 몇 가지 기회가 있습니다. 구강붕해정이나 츄어블 정제와 같은 혁신적인 제형의 개발은 환자들에게 편의성과 복용의 용이성을 제공합니다. 실데나필 제네릭 의약품의 출현은 의약품을 보다 저렴하고 쉽게 구할 수 있게 함으로써 시장 성장을 가속할 것으로 예측됩니다.
본 조사의 주요 특징
본 보고서는 2024년을 기준 연도로 하여 2025-2032년까지의 예측 기간 동안 시장 규모(US$ 10억 달러) 및 연평균 성장률(CAGR)을 포함한 실데나필 의약품 시장에 대해 상세하게 분석하였습니다.
이 연구는 다양한 시장 부문에 걸친 잠재적 수익 기회를 탐색하고 이 시장에 대한 매력적인 투자 제안을 제시합니다.
시장 성장 촉진요인, 저해요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
세계 실데나필(Sildenafil) 의약품 시장의 주요 기업 프로파일에 대해 분석했으며, 기업 배경, 제품 포트폴리오, 주요 실적, 재무 실적, 전략 등에 대해 조사하여 전해드립니다.
이 보고서가 제공하는 통찰력을 통해 마케팅 담당자와 경영진은 제품 출시, 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들이 이 보고서의 통찰력을 통해 이익을 얻을 수 있을 것입니다.
이해관계자들은 실데나필 의약품 시장 분석에 사용된 전략 매트릭스를 활용하여 의사결정 과정을 촉진할 수 있습니다.
목차
제1장 조사 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
성장 촉진요인
성장 억제요인
기회
주요 하이라이트
규제 시나리오
최근 동향
제품 발매 및 승인
PEST 분석
PORTER 분석
합병, 인수, 광고 협업
제4장 실데나필 의약품 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급측과 수요측 분석
경제에 대한 영향
제5장 실데나필 의약품 시장, 약물 유형별, 2020년-2032년
브랜드 의약품
제네릭 의약품
시판약
제6장 실데나필 의약품 시장, 적응증별, 2020년-2032년
발기부전
폐동맥 고혈압
양성 전립선 비대증
기타(조루, 고산병)
제7장 실데나필 의약품 시장, 유통 채널별, 2020년-2032년
병원 약국
소매 약국
온라인 약국
기타(클리닉, 통신판매 약국)
제8장 실데나필 의약품 시장, 제형별, 2020년-2032년
정제
경구 젤리
주사
기타(현탁액, 캡슐)
제9장 실데나필 의약품 시장, 지역별, 2020년-2032년
북미
미국
캐나다
유럽
독일
영국
프랑스
이탈리아
스페인
러시아
기타 유럽
아시아태평양
중국
인도
일본
호주
한국
ASEAN
기타 아시아태평양
라틴아메리카
브라질
멕시코
아르헨티나
기타 라틴아메리카
중동
GCC 국가
이스라엘
기타 중동
아프리카
남아프리카
중앙아프리카
북아프리카
제10장 경쟁 구도
기업 개요
Pfizer
Teva Pharmaceuticals
Aurobindo Pharma
Alembic Pharmaceuticals
Torrent Pharmaceuticals
Lupin
Reddy's Laboratories
Zydus Cadila
Amneal Pharmaceuticals
Hetero
Apotex
Mylan
Ajanta Pharma
Sun Pharmaceutical
Cipla
Novartis
Eli Lily
Sanofi
Bayer
GlaxoSmithKline
제11장 섹션
참고 문헌
조사 방법
출판사에 대해
LSH
영문 목차
영문목차
Sildenafil Drug Market is estimated to be valued at USD 3.3 Bn in 2025 and is expected to reach USD 5.2 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 3.3 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
6.70%
2032 Value Projection:
USD 5.2 Bn
Sildenafil which is commonly known as the little blue pill, is a widely used drug primarily used to treat erectile dysfunction (ED). It belongs to the class of medications called phosphodiesterase type 5 (PDE5) inhibitors and is marketed under the brand name Viagra. Sildenafil works by relaxing the smooth muscles of the blood vessels in the penis, thereby allowing for increased blood flow and ultimately facilitating an erection.
Since its introduction in the late 1990s, sildenafil has revolutionized the field of ED treatment, providing relief to millions of men worldwide. It has become the go-to medication for individuals experiencing difficulties in achieving and maintaining an erection, thereby offering an effective solution that has transformed the lives of many.
Market Dynamics:
The sildenafil drug market is expected to witness significant growth in the forecast period. The key drivers for this growth include the increasing prevalence of erectile dysfunction worldwide, the growing aging population, and the rising awareness regarding sexual health.
However, the market has also challenges. The significant restraint is the presence of counterfeit sildenafil products in the market, which can pose serious health risks to consumers. Regulatory bodies and pharmaceutical companies are making efforts to crack down on counterfeit drugs.
Despite these challenges, the sildenafil market presents several opportunities. The development of innovative dosage forms, such as orally disintegrating tablets and chewable tablets, offers convenience and ease of administration for patients. The emergence of generic versions of sildenafil is expected to drive the market growth by making the drug more affordable and accessible.
Key Features of the Study:
This report provides an in-depth analysis of the sildenafil drug market, including market size (in US$ Bn) and compound annual growth rate (CAGR %) for the forecast period of 2025-2032, with 2024 as the base year
The study explores potential revenue opportunities across different market segments and presents attractive investment propositions for this market
It offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
The report profiles key players in the global sildenafil drug market, highlighting their company background, product portfolio, key accomplishments, financial performance, and strategies
The study includes key companies such as Pfizer, Teva Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Torrent Pharmaceuticals, Lupin, Dr Reddy's Laboratories, Zydus Cadila, Amneal Pharmaceuticals, Hetero, Apotex, Mylan, Ajanta Pharma, Sun Pharmaceutical, Cipla, Novartis, Eli Lily, Sanofi, Bayer, and GlaxoSmithKline.
The insights provided by this report would enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
Various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, would benefit from the findings of this report
Stakeholders can leverage the strategy matrices used in analyzing the sildenafil drug market to facilitate decision-making processes
Detailed Segmentation:
Sildenafil Drug Market, By Drug Type
Branded Drugs
Generic Drugs
Over The Counter Drugs
Sildenafil Drug Market, By Indication
Erectile Dysfunction
Pulmonary Arterial Hypertension
Benign Prostatic Hyperplasia
Others (Premature Ejaculation, Altitude Sickness)
Sildenafil Drug Market, By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others (Clinics, Mail Order Pharmacies)
Sildenafil Drug Market, By Dosage Form
Tablets
Oral Jellies
Injections
Others (Suspensions, Capsules)
Sildenafil Drug Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles
Pfizer
Teva Pharmaceuticals
Aurobindo Pharma
Alembic Pharmaceuticals
Torrent Pharmaceuticals
Lupin
Reddy's Laboratories
Zydus Cadila
Amneal Pharmaceuticals
Hetero
Apotex
Mylan
Ajanta Pharma
Sun Pharmaceutical
Cipla
Novartis
Eli Lily
Sanofi
Bayer
GlaxoSmithKline
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Indication
Market Snippet, By Distribution Channel
Market Snippet, By Dosage Form
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing prevalence of erectile dysfunction
Restraints
Adverse effects and safety concerns
Opportunities
Development of novel drug delivery system
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, ad Collaborations
4. Sildenafil Drug Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Sildenafil Drug Market, By Drug Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Branded Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Generic Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Over The Counter Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Sildenafil Drug Market, By Indication, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Erectile Dysfunction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pulmonary Arterial Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Benign Prostatic Hyperplasia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Premature Ejaculation, Altitude Sickness)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Sildenafil Drug Market, By Distribution Channel, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Clinics, Mail Order Pharmacies)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Sildenafil Drug Market, By Dosage Form, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Oral Jellies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Injections
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others (Suspensions, Capsules)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Sildenafil Drug Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021 -2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
